Date post: | 06-Jul-2018 |
Category: |
Documents |
Upload: | irahmal-irahmal |
View: | 221 times |
Download: | 0 times |
of 37
8/17/2019 CHEMOTHERAPY CANCER.pptx
1/37
CHEMOTHERAPY CANCER
Oleh :Dimas P.NugrahaBagian farmakologi F !R
8/17/2019 CHEMOTHERAPY CANCER.pptx
2/37
Chemo"hera#$ is "he use of %rugs "o
8/17/2019 CHEMOTHERAPY CANCER.pptx
3/37
• Tumor &ells &an 'e &lassi(e% as proliferatingcells and non-proliferating cells.
• The ra"io of #rolifera"ing &ells in "he )hole
"umor "issue is &alle% gro)"h fra&"ion *+F,.• The fas"er "he "umor &ells #rolifera"e- "he
'igger "he +F is an% "he higher "hesensi"ii"$ of "umor "o a %rug is.
• +enerall$- in the early stage, the GF of atumor is bigger and the eect of a drug onthe tumor is better.
8/17/2019 CHEMOTHERAPY CANCER.pptx
4/37
Base% on "he DNA &hanges in &ells- #rolifera"ing &$&le of"umor &ells &an 'e %ii%e% in"o / #hases
• Pre-synthetic phase *+a# 0 #hase or +0 #hase,.&ells &hie1$ make #re#ara"ions for "he s$n"hesis ofDNA.
• Synthetic phase *2 #hase,. &ells are s$n"hesi3ing"heir DNA.
• Post-synthetic phase *+a# 4 #hase or +4 #hase,.DNA %u#li&a"ion has 'een (nishe% an% "he$ are
e5uall$ %ii%e% "o "he ")o of fu"ure su'6&ells.• Mitosis phase *M Phase,. ea&h &ell is %ii%e% in"o ")o
su'&ells. 2ome of "hese ne) &ells en"er "he ne)#rolifera"ing &$&le- "he o"hers 'e&ome non6#rolifera"ing &ells.
8/17/2019 CHEMOTHERAPY CANCER.pptx
5/37
• Non6#rolifera"ing &ells in&lu%e G phase cells• *res"ing6#hase &ells,-
• + 7 #hase &ells hae #rolifera"ion a'ili"$
'u" %o no" %ii%e "em#orall$.• 8hen #rolifera"ing &ells are su9ere% hea$
&asual"ies- + #hase &ells )ill ge" in"o#rolifera"ing &$&le an% 'e&ome "he reasons
of "umor re&urren&e.• +7 #hase &ells are usuall$ not sensitive to
antineoplasticdrugs, which is the importantobstacle "o "umor &hemo"hera#$.
8/17/2019 CHEMOTHERAPY CANCER.pptx
6/37
Mechanisms of Antineoplastic Drugs
Mos" an"ineo#las"i&%rugs a&" on "he#rolifera"ing &$&le of &ell
( 1) destruction of DNA or inhibitionof DNA duplication
e.g. alk$la"ingagen"s- mi"om$&inC
*2) inhibition of nucleic acid (DNAand NA) synthesis
e.g. 61uoroura&il- ;6mer&a#"o#urine-me"ho"re
8/17/2019 CHEMOTHERAPY CANCER.pptx
7/37
( !) "nterfering #ith the transcription toinhibit NA synthesis
e.g. %a&"inom$&in- %auorui&in- an%
%o
8/17/2019 CHEMOTHERAPY CANCER.pptx
8/37
&lassi'cation of Antineoplastic Drugs
On "he 'asis of an"ineo#las"i& a&"ion on "he #haseof #rolifera"ion &$&le- %rugs are &lassi(e% as
• cell cycle non-specifc agents *#hasenons#e&i(& agen"s- CCN2A, *e.g. alk$la"ingagen"s,
6 A&" in all #rolifera"ing #hases- een "he +
6 e9e&"s are s"ronger.
• cell cycle specifc agents (phase specifcagents, CC2A,. *e.g. An"ime"a'oli"es-in&aalkaloi%s,
6 =us" a&" on s#e&i(& #hases of "he &ell &$&le
6 e9e&"s are &om#ara"iel$ )eaker.
8/17/2019 CHEMOTHERAPY CANCER.pptx
9/37
On "he 'asis of sour&e an% a&"ionme&hanisms- "he %rugs are also&lassi(e% as:
• alk$la"ing agen"s-
• an"ime"a'oli"es-
•
na"ural #ro%u&"s-• hormones an% an"agonis"s
• mis&ellaneous agen"s.
8/17/2019 CHEMOTHERAPY CANCER.pptx
10/37
• Alk$la"ingagen"s a&" ia a rea&"ie alk$l*RCH 4 >CH 6 4 ?, grou# "ha" rea&"s "oform &oalen" 'on%s )i"h nu&lei& a&i%s.
• There follo)s ei"her &ross6linking of "he")o s"ran%s of DNA- #reen"ingre#li&a"ion- or DNA 'reakage.
6 All alk$la"ingagen"s are #has#hase
nons#e&i(&
6 kill ra#i%l$ #rolifera"ing &ells- also killnon#rolifera"ing &ells.
8/17/2019 CHEMOTHERAPY CANCER.pptx
11/37
• amples* Mechlorethamine 6 "he (rs" %rug use% in "he "rea"men" of
&an&er
6 A" #resen"- i" is mainl$ use% for Ho%gkin@s%isease an% non6Ho%gkin@s l$m#homas.
• amples* &yclophosphamide
6 Mos" )i%el$ use% in &lini&al "hera#$ for
"rea"men" of &an&er a" #resen". 6 " has no an"ineo#las"i&a&"ion ou"si%e
"he 'o%$ an% mus" 'e a&"ia"e%in "he lier
8/17/2019 CHEMOTHERAPY CANCER.pptx
12/37
8/17/2019 CHEMOTHERAPY CANCER.pptx
13/37
• An"ime"a'oli"es are analogues of normalme"a'oli"es an% a&" '$ &om#e"i"ion-re#la&ing "he na"ural me"a'oli"e an% "hen
su'er"ing &ellular #ro&esses.• E
8/17/2019 CHEMOTHERAPY CANCER.pptx
14/37
• ample* methotreate
6 Mimi&s foli& a&i%- )hi&h is nee%e%for s$n"hesis of DNA- RNA an% someamino a&i%s
6 " a&"s mainl$ on "he 2 #hase &ells.
6 has a serious m$elosu##ression
8/17/2019 CHEMOTHERAPY CANCER.pptx
15/37
• ample* +-Mercaptopurine
6 A s"ru&"ural analogue of h$#o
8/17/2019 CHEMOTHERAPY CANCER.pptx
16/37
• ample* %-,luorouracil (%-,) 6 a 1urorine6su's"i"u"e% analogue of ura&il
6 mus" 'e me"a'oli&all$ a&"ia"e% "o a
nu&leo"i%e- in "his &ase F%!MP.6 "hen i"s me"a'oli"e inhi'i"s "he s$n"he"aseof %eo
8/17/2019 CHEMOTHERAPY CANCER.pptx
17/37
8/17/2019 CHEMOTHERAPY CANCER.pptx
18/37
Natural Products
• This grou# is %e"ermine% '$ "he sour&e of"he %rug
• The ma=or &lasses of na"ural #ro%u&"s in&lu%e
6 an"i'io"i&s 6 in&aalkaloi%s
6 'iologi& res#onse mo%i(ers
6 en3$mes
6 e#i#o%o#h$llo"o
8/17/2019 CHEMOTHERAPY CANCER.pptx
19/37
• Antibiotic antineoplasticagents
Damage DNA in &$&ling an% non&$&ling&ells
• E
8/17/2019 CHEMOTHERAPY CANCER.pptx
20/37
/inca(plant) al0aloids• in&ris"ine an% in'las"ine are alkaloi%s
%erie% from "he #eri)inkle #lan".
•
'in%ing "o "u'ulin- in"erfere )i"h "heassem'l$ of s#in%le #ro"eins %uring mi"osis
• A&" in M #hase "o inhi'i" mi"osis- 'lo&king#rolifera"ing &ells as "he$ en"er me"a#hase.
• Bo"h &an &ause 'one marro) su##ressionan% neuro"o
8/17/2019 CHEMOTHERAPY CANCER.pptx
21/37
8/17/2019 CHEMOTHERAPY CANCER.pptx
22/37
• The gro)"h of some &an&ers ishormone %e#en%en". +ro)"h of su&h&an&ers &an 'e inhi'i"e% '$ surgi&al
remoal of hormone glan%s-in&reasingl$- ho)eer- a%minis"ra"ionof hormones or an"ihormonesis
#referre%
8/17/2019 CHEMOTHERAPY CANCER.pptx
23/37
amples*
• Adrenocorticalsteroids "o inhi'i""he gro)"h of &an&ers of l$m#hoi%"issue an% 'loo%.
• strogen antagonists * "amo
8/17/2019 CHEMOTHERAPY CANCER.pptx
24/37
8/17/2019 CHEMOTHERAPY CANCER.pptx
25/37
Miscellaneous agents
amples* ydroyurea
• H$%ro
8/17/2019 CHEMOTHERAPY CANCER.pptx
26/37
8/17/2019 CHEMOTHERAPY CANCER.pptx
27/37
• n or%er "o enhan&e &ura"ie e9e&"- "o %e&rease"he "o
8/17/2019 CHEMOTHERAPY CANCER.pptx
28/37
1 Select drugs according to theirphase speci'c characteristics
• The aim of "his rule is "o urge more +7 #hase &ells "o en"er "he#rolifera"ing &$&le so as "o in&rease"he amoun" of "umor &ells kille% '$
%rugs.
Principles of combinationtherapies
8/17/2019 CHEMOTHERAPY CANCER.pptx
29/37
• For high +F "umor su&h as a&u"e leukemia-#hase s#e&i(& %rugs are (rs"l$ use% "o kill 2 or M#hase &ells- an% "hen #hase non6s#ei&(& %rugsare use% "o kill "umor &ells in o"her #hases- an%
(nall$ "he a'oe ")o s"e#s are re#ea"e% on&eagain "o kill ne) &ell from + 7 #hase.
• For lo) +F "umor su&h as soli% "umors- #hasenon6s#e&i(& %rugs are (rs"l$ use% "o kill &ells of
all #hases- an% "hen #hase s#e&i(& %rugs areuse%- an% (nall$ "he a'oe s"e#s are re#ea"e% "okill "he ne) &ell from +7 #hases.
8/17/2019 CHEMOTHERAPY CANCER.pptx
30/37
4 &ombinations of antineoplasticdrugs#ith di3erent action mechanisms.
&an %es"ro$ "umor &ells from arious
'io&hemi&al links a" same "ime. &ombinations of antineoplasticdrugs
#ith other therapies
E
8/17/2019 CHEMOTHERAPY CANCER.pptx
31/37
$ &ombination of lo#-toic drugs#ith hightoic ones
%oes no" o'iousl$ in&rease "he "o
8/17/2019 CHEMOTHERAPY CANCER.pptx
32/37
. 2ele&" %rugs a&&or%ing "o
8/17/2019 CHEMOTHERAPY CANCER.pptx
33/37
4oi
Short-term toicity
• Common si%e rea&"ions usuall$a##ear earlier an% man$ of "hem o&&ur
in ra#i%#rolifera"ing "issues su&h asmarro)- gas"roin"es"inal "ra&"- an% hairfolli&le.
•
m$elosu##ression-• gas"roin"es"inal "ra&" s$m#"om
• alo#e&ia
8/17/2019 CHEMOTHERAPY CANCER.pptx
34/37
5ong-term toicity
• The long6"erm "o
8/17/2019 CHEMOTHERAPY CANCER.pptx
35/37
The cell cycle and the relationship oantitumor drug action to the cycle
8/17/2019 CHEMOTHERAPY CANCER.pptx
36/37
8/17/2019 CHEMOTHERAPY CANCER.pptx
37/37
One of "he grea"es" &hallen